Washington DC [US], July 29 (ANI/Sputnik): The efficacy of the Pfizer/BioNTech coronavirus vaccine fell from 96% to 84% after six months, a new preprint report by medRxiv showed on Wednesday.
New Delhi [India], July 27 (ANI): Morepen Laboratories said on Tuesday it registered a growth of 97 per cent in consolidated profit before tax at Rs 38 crore during the quarter ending June 30.
New Delhi [India], July 24 (ANI): Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria informed.
New Delhi [India], July 23 (ANI): Amid reports of shortage of COVID-19 vaccines from several parts of the country, the Central government on Friday informed that more than 2.75 crore unutilised doses are still available with states, union territories and private hospitals.
New Delhi [India], July 22 (ANI): The Delhi government on Thursday said that doses of the Covishield coronavirus vaccine will be reserved only for those eligible for the second dose with immediate effect till July 31 due to its limited supply.
New Delhi [India], July 14 (ANI): India has administered 39,10,53,156 doses of coronavirus vaccine in its ongoing inoculation drive so far, informed the Union Health Ministry on Wednesday.
New Delhi [India], July 13 (ANI): Aiming to vaccinate all its citizens against COVID-19, India has administered over 38.50 crore doses of coronavirus vaccine in its ongoing inoculation drive so far.
New Delhi [India], July 13 (ANI): With 45 fresh COVID-19 cases in the last 24 hours, Delhi has reported the lowest coronavirus daily count after about 1.25 years, health minister Satyendar Jain informed on Tuesday.
Washington [US], July 13 (ANI): The US Food and Drug Administration (FDA) on Monday (local time) warned coronavirus vaccine maker Johnson & Johnson of possible rare neurological complications caused due to its dose.
Washington DC [US], July 10 (ANI): Looking to kill two birds with one stone, the United States is increasing the delivery of COVID-19 vaccines to Latin American countries to address the region's health plight and curtail China's bid to exert its influence through vaccine exports.